The evidence around Astra Zeneca COVID vaccination has evolved and so the recommendations about vaccination have changed today (17 June 2021)

The Australian Technical Advisory Group on Immunisation (ATAGI) recommendations announce today are:

  • ATAGI advises that Comirnaty is preferred over COVID-19 Vaccine AstraZeneca from the age of 16 to under 60 years. This is based on recent data regarding TTS cases in Australia and a reassessment of current age-specific risks and benefits of vaccination.
  • ATAGI considers the benefit of vaccination in preventing COVID-19 with COVID-19 Vaccine AstraZeneca outweighs the risk of TTS in people aged 60 and above. For this age group, the benefits of receiving a COVID-19 vaccine are greater than in younger people. The risks of severe outcomes with COVID-19 increase with age and are particularly high in older unvaccinated individuals.
  • COVID-19 Vaccine AstraZeneca can be used in adults aged under 60 years for whom Comirnaty is not available, the benefits are likely to outweigh the risks for that individual and the person has made an informed decision based on an understanding of the risks and benefits.
  • People of any age without contraindications who have had their first dose of COVID-19 Vaccine AstraZeneca without any serious adverse events should receive the second dose.
  • ATAGI reinforces the importance of providing clear communications to people who have received or are considering COVID-19 Vaccine AstraZeneca, and notes guidance documents for consumers, for primary care and for hospitals are being continually revised to accommodate this new recommendation.

Read the full recommendation here:

Other recent changes include a shortening of the time between COVID and infleunza immnisations to 7 days rather than the original 14 days.

Previous Post
You can get an immunisation history statement or COVID-19 digital certificate to show proof of your coronavirus (COVID-19) vaccinations.
Next Post
After 40 years in medical practice and over 36 years of serving the Mount Gravatt community Dr Annette Kortlucke has retired.

Related Posts

No results found.